How to Select Clinically Relevant Targets for Infectious Disease Panels | AACC.org - American Association for Clinical Chemistry (AACC)
Designing infectious disease panels isn't as easy as picking a few targets off a list and sticking them into one test. Clinical laboratories must factor in many different considerations, from the pathogens physicians are already testing for, to available laboratory equipment, to inpatient versus outpatient status. Since the COVID-19 pandemic, physicians are also more aware of the power of molecular testing. So how should clinical laboratories approach creating and evaluating infectious disease panels? We spoke to Stella Antonara, PhD, D(ABMM), medical director of microbiology at OhioHealth Laboratory Services, about this, and about how the changing role of point-of-care testing could affect infectious disease testing in the future. When you build a molecular panel for infectious disease testing, what are the top considerations you have to weigh? The first thing we do is review the list of the tests our providers send out the most. What are their needs? Do they test for a spec